Market Overview

Benzinga's Top Initiations

Benzinga's Top Initiations
Related PFE
#PreMarket Movers From December 18, 2014: Rite Aid, Oracle, GoPro And More
Opko Health Inks Pfizer License Pact
Divided Government Won't Halt Street's Run (Fox Business)
Related LNKD
After Oppenheimer's Latest Rating On Twitter, Here's How Peers Are Looking
LinkedIn, Other Internet Stocks Reaching Record Highs
Skyworks CEO on Mobile Connectivity Benefits (Fox Business)

Analysts at Citigroup initiated coverage on shares of Pfizer (NYSE: PFE) with a “buy” rating. Pfizer's shares closed at $24.85 yesterday. Pfizer's trailing-twelve-month operating margin is 31.27%.

Wedbush initiated coverage on shares of LinkedIn (NYSE: LNKD) with a “neutral” rating. LinkedIn's stock closed at $107.11 yesterday. LinkedIn's trailing-twelve-month ROE is 2.76%.

Wells Fargo initiated coverage on shares of Hess (NYSE: HES) with a “market perform” rating. Hess' shares closed at $50.50 yesterday. Hess had $528.00 million in total cash for the recent quarter.

Analysts at Mizuho initiated coverage on shares of Salix Pharmaceuticals (NASDAQ: SLXP) with a “buy” rating. Salix's shares closed at $41.26 yesterday. Salix's PEG ratio is 0.62.

Latest Ratings for PFE

DateFirmActionFromTo
Dec 2014Deutsche BankMaintainsBuy
Oct 2014JefferiesMaintainsBuy
Aug 2014Deutsche BankInitiates Coverage onBuy

View More Analyst Ratings for PFE
View the Latest Analyst Ratings

Posted-In: Top InitiationsInitiation Analyst Ratings

 

Related Articles (HES + LNKD)

Around the Web, We're Loving...

Get Benzinga's Newsletters